Equities

Patterson Companies Inc

Patterson Companies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)20.46
  • Today's Change0.175 / 0.86%
  • Shares traded607.75k
  • 1 Year change-36.69%
  • Beta0.9831
Data delayed at least 15 minutes, as of Nov 22 2024 19:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy2
Outperform0
Hold10
Sell1
Strong Sell0

Share price forecast in USD

The 9 analysts offering 12 month price targets for Patterson Companies, Inc. have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 22.00. The median estimate represents a 28.21% increase from the last price of 20.28.
High47.9%30.00
Med28.2%26.00
Low8.5%22.00

Dividends in USD

In 2024, Patterson Companies Inc reported a dividend of 1.04 USD, equaling last years dividend. The 5 analysts covering the company expect dividends of 1.05 USD for the upcoming fiscal year, an increase of 0.58%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Aug 28, 2024, Patterson Companies, Inc. reported 1st quarter 2025 earnings of 0.24 per share.
The next earnings announcement is expected on Nov 27, 2024.
Average growth rate+2.81%
Patterson Companies, Inc. reported annual 2024 earnings of 2.30 per share on Jun 18, 2024.
Average growth rate+10.93%
More ▼

Revenue history & estimates in USD

Patterson Companies, Inc. had 1st quarter 2025 revenues of 1.54bn. This missed the 1.59bn consensus estimate of the 9 analysts following the company. This was 2.22% below the prior year's 1st quarter results.
Average growth rate-0.33%
Patterson Companies, Inc. had revenues for the full year 2024 of 6.57bn. This was 1.50% above the prior year's results.
Average growth rate+4.67%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.